Scientists have developed a specially formulated bioink, which contains microparticles engineered for sustained delivery of insulin-like growth factor-1 (IGF-1). This delivery enhances the formation of mature skeletal muscle tissue from muscle precursor cells and facilitates their structural alignment, leading to more efficient regeneration of functional skeletal muscle tissue. This, in turn, can lead to successful therapies for people suffering from muscle loss or injury.
Click here for original story, New and improved bioink to enhance 3D bioprinted skeletal muscle constructs
Source: ScienceDaily